about
On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a reviewIGF-I in the clinics: Use in retinopathy of prematurityInsulin-like growth factor 1 has multisystem effects on foetal and preterm infant developmentThe mouse retina as an angiogenesis model.Ocular dimensions in relation to auxological data in a sample of Swedish children aged 4-15 years.Visually impaired children with posterior ocular malformations: pre- and neonatal data and visual functions.Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice.Morphological aspects of dental hard tissues in primary teeth from preterm infants.Aggressive Posterior Retinopathy of Prematurity Is Associated with Multiple Infectious Episodes and Thrombocytopenia.Retinopathy of prematurity: the need for prevention.Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safetyThe clinical and morphologic spectrum of optic nerve hypoplasia.Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity.[The early postnatal weight gain as a predictor of retinopathy of prematurity].Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm childrenWINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infantsPosterior ocular malformations in children: somatic, neuroradiological and cognitive aspects.Weight at first detection of retinopathy of prematurity predicts disease severity.Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.Optic disc morphology may reveal timing of insult in children with periventricular leucomalacia and/or periventricular haemorrhage.Visual and ocular findings in children adopted from eastern Europe.Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infantsIncreased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesisLow IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathyRetinal Sequelae in Adults Treated With Cryotherapy for Retinopathy of Prematurity.Cerebellar Exposure to Cell-Free Hemoglobin Following Preterm Intraventricular Hemorrhage: Causal in Cerebellar Damage?White matter damage after chronic subclinical inflammation in newborn mice.Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.Visual and cerebral sequelae of very low birth weight in adolescents.Nutrition, insulin-like growth factor-1 and retinopathy of prematurityVisual impairment is common in children born before 25 gestational weeks--boys are more vulnerable than girls.New insights into the development of retinopathy of prematurity--importance of early weight gain.Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report
P50
Q27025624-3B079CB2-B3FA-482D-84D9-2678799E3553Q28070089-0BE68ADB-6881-4B35-842B-4947F2BC7261Q28073109-7131FF98-860B-40A3-8F3A-0EFB8A1A4458Q30495106-5C0A59E2-B8E8-41AD-828E-02AA62195135Q30738960-7CF40E9C-2C13-4CD9-AD24-EF05F00C3290Q30811695-63EF57AA-87FE-436A-9721-6F3F2C1BB795Q30853111-D893625D-B959-46C9-B78F-DC4B574C9EBFQ33352796-0D74A22E-6777-46E5-9425-5FABD65E8CD9Q33435378-E8CEE296-7BFE-415F-8D11-0642711E45C9Q33585466-FBF753D5-74B2-4F70-AADA-22D807441C4EQ33640027-55A02702-AD33-4B44-AC2E-40A77DB833AFQ33728741-D0AE9BDE-3E46-49B4-A332-9D077C786069Q33760906-F266C487-7A64-4146-969C-D70A8939AE40Q33870026-165A805D-8B65-42A9-9276-81CA5C7BBC5BQ34339456-7C8116B4-EC14-4A11-A9FD-987E0A5C7A11Q34343703-231FE805-6568-4D77-81F9-4CF872F7C30BQ34358139-61566164-9256-4BCE-AF19-8D50A7BD1516Q34617800-827F3371-14EA-4781-A7EA-3CD1BF0861A4Q34998606-0BAFBA91-75D7-4E1D-A56D-DFD34EC50268Q35119106-B5EB4D86-CD24-4A03-9753-F1A3FE5293D3Q35316451-2E17AA96-DEEC-4D33-A00F-F744EEE1CF5CQ35370567-8D96A00C-391C-46C3-8C51-45936AB03B3CQ35591542-CC8DB172-434C-4730-A1E2-07C183C037FCQ35592585-4CA6010E-9AF9-4B81-91E5-73BCCF373024Q35776253-EAA8540D-0CD9-4CBC-AD6E-50A704D48514Q35800245-659CE103-0196-45D3-AFF3-69EA83F99201Q35817458-86B76BF4-549E-4023-B3A2-08DBBF41D3D8Q35897076-3FF0E6C1-9DA0-4EA4-9979-953C9918DE34Q35954872-88F11DC5-BD56-4369-9321-5B9167E243D8Q35973404-A69FDD05-286A-49FD-9146-71D53F760418Q36035023-ACD93E59-6571-4BB6-BEC8-353C0D9C9E1FQ36106946-179B43D0-6D8C-4605-A58F-45AA193A732BQ36397625-21ED06D6-B688-4AFD-8608-116FCFBD8FBBQ36907520-13F1FC32-28A7-450D-9498-01A76007B71FQ37011339-E10DE474-AC7B-4424-A31E-51E98A223DC5Q37174855-09CCF824-9953-40B2-8217-E0CAD6EFA180Q37258163-71F5A9BB-A343-4EFE-8AB4-9A5483A331F7Q37281606-0C9A2A1E-8820-4963-8457-FD05F3395418Q37624795-2A27435D-F9A0-4AC5-BEE3-A5C236A784F4Q37733656-10F379BE-DE23-4664-94BC-7496D08AFDF4
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
researcher
@en
svensk forsker
@nb
հետազոտող
@hy
name
Ann Hellström
@ast
Ann Hellström
@da
Ann Hellström
@de
Ann Hellström
@en
Ann Hellström
@es
Ann Hellström
@fr
Ann Hellström
@nb
Ann Hellström
@nl
Ann Hellström
@nn
Ann Hellström
@sl
type
label
Ann Hellström
@ast
Ann Hellström
@da
Ann Hellström
@de
Ann Hellström
@en
Ann Hellström
@es
Ann Hellström
@fr
Ann Hellström
@nb
Ann Hellström
@nl
Ann Hellström
@nn
Ann Hellström
@sl
altLabel
Knattan
@en
prefLabel
Ann Hellström
@ast
Ann Hellström
@da
Ann Hellström
@de
Ann Hellström
@en
Ann Hellström
@es
Ann Hellström
@fr
Ann Hellström
@nb
Ann Hellström
@nl
Ann Hellström
@nn
Ann Hellström
@sl
P106
P1153
7007157089
P21
P27
P31
P496
0000-0002-9259-1244